New Jersey A 3987: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2018-05-17)

State: New Jersey · Session: 218 · Bill: A 3987

Subjects: PHARMACEUTIC

Sponsors: Armato, John, DeCroce, BettyLou, Murphy, Carol A., Calabrese, Clinton

View New Jersey A 3987 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.